Novo Nordisk shares rise 2.11% in premarket trading amid broader market pressure from higher-than-expected inflation data.
Stock index futures declined Tuesday after a retail inflation report exceeded expectations, adding pressure to markets already concerned over geopolitical tensions. U.S. futures pointed lower as investors assessed the implications of persistent inflation on monetary policy.
Novo Nordisk (NVO) stood out in premarket trading, gaining 2.11%. The broader market faced headwinds from fears of a potential collapse in the U.S.-Iran ceasefire, further dampening sentiment. Other stocks on investors’ radar included Bristol-Myers Squibb (BMY), Alphabet (GOOG), and Broadcom (AVGO).
The inflation data reinforced concerns about the Federal Reserve’s rate path, with markets pricing in potential delays to anticipated cuts. The report’s impact overshadowed individual stock movements early in the session.